Defendants not only knew or should have known that their GLP-1RAs cause delayed gastric emptying, resulting in risks of gastroparesis, but they may have sought out the delayed gastric emptying effect due to its association with weight loss. A study published in October found that Ozempic triples the risk of the stomach paralysis among users when compared to users of non-injectable weight loss drugs
Elevated plasma fatty acid levels, being associated with an increased risk of HF, can give rise to lipotoxicity (81)
Sterne JAC, Savovi J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H, Corbett MS, Eldridge SM, Emberson JR, Hernn MA, Hopewell S, Hrbjartsson A, Junqueira DR, Jni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT
The most common discharge pattern on the EEG is burst suppression, followed by high amplitude dysrhythmias and multi-spike discharges, with corresponding changes in the EEG after the patient receives PN treatment [27]
ADVOKATBYRN KRUSE & CO Hamntorget 5 252 21 Helsingborg 042-28 25 00 [email protected]
Dosage Considerations and Administration Routes In clinical trials of GLP-1 peptide Cagrilintide, it is injected under the skin, and the doses are usually started low and gradually increased until they reach effective levels over a number of weeks